Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comparison of Diagnostic Performance and Cost-effectiveness of US and Abbreviated MRI for Hepatocellular Carcinoma Screening

NCT05828446 is registered in ClinicalTrials.gov with Naik Vietti Violi as lead sponsor.

NCT NCT05828446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05828446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comparison of Diagnostic Performance and Cost-effectiveness of US and Abbreviated MRI for Hepatocellular Carcinoma Screening
Lead sponsor
Naik Vietti Violi
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2023
Completion date
April 30, 2027
Enrollment
330 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-enhanced us, hepatocellular carcinoma, magnetic resonance imaging, screening